Study Type
Interventional - Drug
ANNEXa-1 is a randomized, multicenter, Phase 4 clinical trial of 440 patients designed to determine the efficacy and safety of andexanet compared to usual care in patients presenting with acute intracranial hemorrhage.
Interventional - Drug
Prospective open-label RCT
10
100
440
2019 - 2022
Portola Pharmaceuticals
Back To Top